HIV and Hepatitis.com Coverage of the
13th Annual Conference on Retroviruses
and Opportunistic Infections (13th CROI)
February 5 - 8, 2006, Denver, CO
Table of Contents
Just Released !!  POST CROI 2006 CME/CE Update

Highlights from the 13th CROI: CME Slide Kit with Audio

Trials in Treatment-naive Patients — Richard Elion, MD
New Treatments and Treatment Interruption — Calvin Cohen, MD
Adverse Events — Graeme Moyle, MD
Management — Brian Boyle, MD

To access the Slide Presentation and obtain CME/CE credit, CLICK HERE.
* This coverage is not sanctioned by the conference organizers and is not an
official part of the conference.
Library of Slides and Posters
FDA-approved Anti-HIV Drugs
 - Protease Inhibitors (PIs)
 - Non Nucleoside Reverse Transcriptase Inhibitors (nNRTIs)
 - Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (NRTIs)
 - Boosted Protease Inhibitors
Experimental Antiretrovirals
Antiretroviral Drug Toxicities and Other Complications of HIV Disease
Antiretroviral Treatment Strategies
Adherence to Therapy
Dosing
HIV Drug Resistance
HIV Health Care Costs
HIV-HCV and HIV-HBV Coinfection
Immunotherapy
Injection Drug Use
Metabolic Complications and Morphologic (body shape) Changes
Pharmacology, Pharmacokinetics and Drug-drug Interactions
Sexually Transmitted Diseases (STDs)
 Virologic Rebound and Virologic Failure
Virologic Response / Virologic Suppression
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

oi 13th croi 13 13 13croi 13thcroi 13croi

HOME
HIV and AIDS
Hepatitis C
Hepatitis B